52 - European and International Regulatory Perspectives (S21E3) episode artwork

EPISODE · Jun 2, 2025 · 18 MIN

52 - European and International Regulatory Perspectives (S21E3)

from From Concept to Medicine - A Comprehensive Drug Development Journey

Explore the European Medicines Agency (EMA) and the ways this group works with international bodies to regulate clinical trials. This podcast episode discusses the ICH harmonization, and how this integrates with global standards, while taking into account the regional differences.Explore ICH's E6R3 draft guideline and ICH's Q series which provides guidance on how to achieve consistent quality in pharmaceutical manufacturing globally. It also covers what regulators in the European Union use. This podcast explores how they navigate differing regulations and how it affects the creation of multinational clinical studies.

Episode metadata supplied by the publisher feed · Published Jun 2, 2025

Embed this episode

NOW PLAYING

52 - European and International Regulatory Perspectives (S21E3)

0:00 18:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of From Concept to Medicine - A Comprehensive Drug Development Journey?

This episode is 18 minutes long.

When was this From Concept to Medicine - A Comprehensive Drug Development Journey episode published?

This episode was published on June 2, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this From Concept to Medicine - A Comprehensive Drug Development Journey episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!